This page is part of the FHIR Specification (v4.6.0: R5 Draft Ballot). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3
Pharmacy Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Encounter, Patient, Practitioner |
Raw XML (canonical form + also see XML Format Specification)
Dispense for Brentuximab Vedotin (NDC code) - IV Chemo - stopped (id = "meddisp0317")
<?xml version="1.0" encoding="UTF-8"?> <MedicationDispense xmlns="http://hl7.org/fhir"> <id value="meddisp0317"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"><p> <b> Generated Narrative</b> </p> <p> <b> status</b> : stopped</p> <h3> Medications</h3> <table> <tr> <td> -</td> </tr> <tr> <td> *</td> </tr> </table> <p> <b> subject</b> : <a> Donald Duck . Generated Summary: Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male</a> </p> <h3> Performers</h3> <table> <tr> <td> -</td> <td> <b> Actor</b> </td> </tr> <tr> <td> *</td> <td> <a> Generated Summary: id: 937223645 (OFFICIAL), id: 134IDY41W988 (USUAL); Rob van den Berk (OFFICIAL); Phone: 0205569288, R.A.vandenberk@bmc.nl, Fax: 0205664987; gender: male; birthDate: 1975-12-07</a> </td> </tr> </table> <p> <b> authorizingPrescription</b> : <a> Generated Summary: id: 12345689 (OFFICIAL); status: completed; intent: order; authoredOn: 2015-01-15; instantiatesUri: http://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Lymphom a-Myeloma/ULYBRENTUX%20Protocol_1Jun2017.pdf</a> </p> <p> <b> type</b> : <span> Trial Fill</span> </p> <p> <b> quantity</b> : 3 415818005</p> <p> <b> daysSupply</b> : 1 Day</p> <p> <b> whenPrepared</b> : 25 Jun. 2015, 12:13:00 pm</p> <p> <b> whenHandedOver</b> : 26 Jun. 2015, 12:13:00 pm</p> <h3> DosageInstructions</h3> <table> <tr> <td> -</td> </tr> <tr> <td> *</td> </tr> </table> </div> </text> <contained> <Medication> <id value="med0306"/> <code> <coding> <system value="http://hl7.org/fhir/sid/ndc"/> <code value="51144-050-01"/> <display value="Adcetris (Brentuximab Vedotin 50mg/10.5ml)"/> </coding> </code> <sponsor> <reference value="Organization/mmanu"/> </sponsor> <doseForm> <coding> <system value="http://snomed.info/sct"/> <code value="421637006"/> <display value="Lyophilized powder for injectable solution (qualifier value) "/> </coding> </doseForm> </Medication> </contained> <status value="stopped"/> <medication> <!-- Linked to a RESOURCE Medication --> <reference> <reference value="#med0306"/> <display value="Brentixumab Vedotin (Adcetris)"/> </reference> </medication> <subject> <reference value="Patient/pat1"/> <display value="Donald Duck "/> </subject> <performer> <actor> <reference value="Practitioner/f006"/> </actor> </performer> <authorizingPrescription> <reference value="MedicationRequest/medrx0316"/> </authorizingPrescription> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/v3-ActCode"/> <code value="TF"/> <display value="Trial Fill"/> </coding> </type> <quantity> <value value="3"/> <system value="http://snomed.info/sct"/> <code value="415818005"/> </quantity> <daysSupply> <value value="1"/> <unit value="Day"/> <system value="http://unitsofmeasure.org"/> <code value="d"/> </daysSupply> <whenPrepared value="2015-06-25T07:13:00+05:00"/> <whenHandedOver value="2015-06-26T07:13:00+05:00"/> <dosageInstruction> <sequence value="1"/> <text value="1.8 mg/kg IV infusion over 30 minutes every 3 weeks for 16 cycles"/> <timing> <repeat> <count value="16"/> <frequency value="1"/> <period value="3"/> <periodUnit value="wk"/> </repeat> </timing> <route> <coding> <system value="http://snomed.info/sct"/> <code value="255560000"/> <display value="Intravenous"/> </coding> </route> <doseAndRate> <type> <coding> <system value="http://terminology.hl7.org/CodeSystem/dose-rate-type"/> <code value="ordered"/> <display value="Ordered"/> </coding> </type> <doseQuantity> <value value="1.8"/> <unit value="mg/kg"/> <system value="http://unitsofmeasure.org"/> <code value="mg/kg"/> </doseQuantity> </doseAndRate> </dosageInstruction> </MedicationDispense>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.